Megan Hudson
Family · Martinsville, VANPI 1104560796
Payments from drug & device makers
Across 175 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$797
- Novartis$215
- Otsuka America Pharmaceutical, Inc.$177
- Novo Nordisk$176
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$173
- AstraZeneca$164
- plus $1K from 31 others
What the payments were for
- Food & beverage$3,175100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $797 |
| Novartis | 11 | $215 |
| Otsuka America Pharmaceutical, Inc. | 8 | $177 |
| Novo Nordisk | 9 | $176 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $173 |
| AstraZeneca | 10 | $164 |
| Lilly USA, LLC | 6 | $118 |
| Optinose US, Inc. | 1 | $113 |
| Pfizer | 7 | $109 |
| Merck | 6 | $107 |
| Xeris Pharmaceuticals, Inc. | 1 | $84 |
| Amgen | 5 | $81 |
| Medicomp Inc | 3 | $81 |
| Lexicon Pharmaceuticals, Inc. | 3 | $77 |
| Boehringer Ingelheim | 4 | $72 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $69 |
| Boston Scientific | 2 | $52 |
| E.r. Squibb & Sons, L.L.C. | 3 | $50 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $47 |
| Philips North America LLC | 1 | $43 |
| Inspire Medical Systems, Inc. | 1 | $38 |
| Astellas Pharma US Inc | 2 | $35 |
| Bayer | 2 | $32 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Alkermes, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $23 |
| Abiomed | 1 | $22 |
| Irhythm Technologies, Inc. | 1 | $22 |
| United Therapeutics Corporation | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Exact Sciences | 1 | $17 |
| Angiodynamics, Inc. | 1 | $16 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $15 |
| Medtronic | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$113
How this compares
$3,189 in reported general payments places this provider in the 85th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 61 | $60,124 |
| RexultiBrexpiprazole | 24 | $35,044 |
| MounjaroTirzepatide | 18 | $19,890 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $18,294 |
| EliquisApixaban | 21 | $17,430 |
| XareltoRivaroxaban | 17 | $14,914 |
| JardianceEmpagliflozin | 14 | $10,580 |
| FarxigaDapagliflozin Propanediol | 14 | $9,077 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $8,497 |
| VascepaIcosapent Ethyl | 15 | $5,245 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,141 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 12 | $1,646 |
| Potassium Chloride | 34 | $1,410 |
| Aripiprazole | 15 | $1,311 |
| Omeprazole | 112 | $1,078 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $176 | $60,12461 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $177 | $35,04424 claims |
| Lilly USA, LLCMounjaro | $118 | $19,89018 claims |
| PfizerEliquis | $109 | $17,43021 claims |
| Johnson & JohnsonXarelto | $14 | $14,91417 claims |
| Boehringer IngelheimJardiance | $72 | $10,58014 claims |
| AstraZenecaFarxiga | $164 | $9,07714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,332 family providers in Virginia.
Other family in Martinsville
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Norman JacobowitzManassas$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.